The TSH receptor reveals itself
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
The thyrotropin receptor (TSHR), one of the primary antigens in autoimmune thyroid disease, is a target of both antigen-specific T cells and antibodies in patients with this condition (1). Autoantibodies to the TSHR (TSHR-Ab) act as thyroid stimulating factor (TSH) agonists in autoimmune hyperthyroidism (Robert Graves disease) but as TSH antagonists in autoimmune hypothyroidism (Hashimoto thyroiditis). The TSHR antigen is primarily expressed in the epithelial cells of the thyroid follicles, but TSHR mRNA and protein have been reported in a variety of cell types, some of which show evidence of receptor activity (Table (Table11). Table 1 Tissue distribution of the TSHR The TSHR gene, cloned in 1989 (2–5), maps to human chromosome 14q and encodes a predicted seven-transmembrane, G protein–coupled glycoprotein. Although it is similar to the luteinizing hormone receptor and the follicle-stimulating hormone receptor, the TSHR is the largest of the glycoprotein hormone receptors, due primarily to 8– and 50–amino acid insertions in its ectodomain (residues 38–45 and 317–367) (6). As predicted from its cDNA, the TSHR has an unglycosylated molecular weight of 84 kDa but the glycosylated holoreceptor runs on SDS-PAGE with an apparent molecular weight of 95–100 kDa. There are six potential N-linked glycosylation sites on the TSHR, and it was recently shown that the TSHR is also palmitoylated (7). The minimal 5′ promoter region required to confer thyroid-specific expression and cAMP autoregulation extends from 220 to 39 bp upstream of the transcription start site, but there are multiple transcription start sites between –89 and –68 bp (8).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Werner & Ingbar's the thyroid : a fundamental and clinical text
Werner, S. C., Ingbar, S. H., Braverman, L. E., & Utiger, R. D. (2012) · Lippincott-Raven eBooks · Cited by 1,016
Li, S., Couet, J., & Lisanti, M. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29182 · Cited by 777
Regulation of Adipocyte Development
Cornelius, P., MacDougald, O. A., & Lane, M. D. (1994) · Annual Review of Nutrition · doi:10.1146/annurev.nu.14.070194.000531 · Cited by 652
The Thyrotropin (TSH)-Releasing Hormone Receptor: Interaction with TSH and Autoantibodies*
Rapoport, B., Chazenbalk, G. D., Jaume, J. C., & McLachlan, S. M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0352 · Cited by 551
Molecular Cloning of the Thyrotropin Receptor
Parmentier, M., Libert, F., Maenhaut, C., Lefort, A., Gérard, C., Perret, J., Van Sande, J., Dumont, J. E., & Vassart, G. (1989) · Science · doi:10.1126/science.2556796 · Cited by 530
Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor
Nagayama, Y., Kaufman, K. D., Seto, P., & Rapoport, B. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92727-7 · Cited by 520
Szkudlinski, M. W., Fremont, V., Ronin, C., & Weintraub, B. D. (2002) · Physiological Reviews · doi:10.1152/physrev.00031.2001 · Cited by 458
Lipid-dependent Targeting of G Proteins into Rafts
Moffett, S., Brown, D. A., & Linder, M. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.2191 · Cited by 429
Laugwitz, K. L., Allgeier, A., Offermanns, S., Spicher, K., Van Sande, J., Dumont, J. E., & Schultz, G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.116 · Cited by 317
Cloning, sequencing and expression of human TSH receptor
Misrahi, M., Loosfelt, H., Atger, M., Sar, S., Guiochon-Mantel, A., & Milgrom, E. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91958-u · Cited by 296
Research works printed but not linked: 13
- 10.1210/er.19.6.673 · DOI
- Wilson, 1968, Endocrinology, 83, 877, 10.1210/endo-83-4-877 · doi:10.1210/endo-83-4-877
- 10.1210/en.130.5.2858 · DOI
- 10.1016/0014-5793(84)80054-X · doi:10.1016/0014-5793(84)80054-x
- 10.1530/eje.0.1370599 · doi:10.1530/eje.0.1370599
- Smith, 1972, J Endocrinol, 52, 229, 10.1677/joe.0.0520229 · doi:10.1677/joe.0.0520229
- 10.1210/en.140.10.4516 · doi:10.1210/en.140.10.4516
- 10.1210/en.141.9.3514 · doi:10.1210/en.141.9.3514
- Latif, 2002, Program Abstr Endocr Soc Annu Meet, 83, 135
- 10.1016/0303-7207(77)90077-6 · doi:10.1016/0303-7207(77)90077-6
- Davies, 1978, Endocrinology, 103, 6, 10.1210/endo-103-1-6 · doi:10.1210/endo-103-1-6
- 10.1210/en.130.4.1857 · DOI
- Marians, 2001, American Thyroid Association 2001 Abstract Guide, 2, 37
Cited by
TSH Is a Negative Regulator of Skeletal Remodeling
Abe, E., Marians, R. C., Yu, W., Wu, X.-B., Ando, T., Li, Y., Iqbal, J., Eldeiry, L., Rajendren, G., Blair, H. C., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00771-2 · Cited by 691
Self-citationRole of Thyroid Hormones in Skeletal Development and Bone Maintenance
Bassett, J. H. D., & Williams, G. R. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1106 · Cited by 540
Current Perspective on the Pathogenesis of Graves’ Disease and Ophthalmopathy
Prabhakar, B. S., Bahn, R. S., & Smith, T. J. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0020 · Cited by 489
Sticky Signaling—Adhesion Class G Protein–Coupled Receptors Take the Stage
Langenhan, T., Aust, G., & Hamann, J. (2013) · Science Signaling · doi:10.1126/scisignal.2003825 · Cited by 267
Thyrotropin receptor-associated diseases: from adenomata to Graves disease
Davies, T. F. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26031 · Cited by 262
Self-citationMazziotti, G., Frara, S., & Giustina, A. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00005 · Cited by 181
The skeletal consequences of thyrotoxicosis
Nicholls, J. J., Brassill, M. J., Williams, G. R., & Bassett, J. H. D. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0059 · Cited by 138
Carella, C., Mazziotti, G., Sorvillo, F., Piscopo, M., Cioffi, M., Pilla, P., Nersita, R., Iorio, S., Amato, G., Braverman, L. E., et al. (2006) · Thyroid · doi:10.1089/thy.2006.16.295 · Cited by 119
Ultra short-loop feedback control of thyrotropin secretion
Prummel, M. F., Brokken, L. J. S., & Wiersinga, W. M. (2004) · Thyroid · doi:10.1089/thy.2004.14.825 · Cited by 100
“This extrathyroidal localization of the TSHR is not as surprising as it used to be, because the receptor has been found in many other tissues (21), including bone (22), retrobulbar tissues (23,24), and dendritic cells (25).”
Leow, M. K.-S. (2007) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2007.05.016 · Cited by 53
Stavreus Evers, A. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00050 · Cited by 36
“…a conformational change, which activates the α-subunit of the heterotrimeric G-protein thereby activating activates cAMP production and activation of proteinkinase A, which mediates most TSH effects, especially its short-term actions (Weiss et al., 1984; Davies et al., 2002; Dremier et al., 2002).”
Fischer, J., Kleinau, G., Rutz, C., Zwanziger, D., Khajavi, N., Müller, A., Rehders, M., Brix, K., Worth, C. L., Führer, D., et al. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2728-1 · Cited by 18
Venugopalan, V., Al-Hashimi, A., Weber, J., Rehders, M., Qatato, M., Wirth, E. K., Schweizer, U., Heuer, H., Verrey, F., & Brix, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115776 · Cited by 2
“In addition, the TSH receptor has the ability to oligomerize with itself [20,21] and with the TH transporter Mct8, thereby potentially further modulating the outcomes of signaling [3,22].”
Background
Metadata
- Authors
- Davies, T., Marians, R., & Latif, R.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-07-15
- Volume
- 110
- Issue
- 2
- Pages
- 161-164
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2028507841
- Cited by
- 203
- References
- 48
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.